Nektar Therapeutics (NASDAQ:NKTR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Nektar Therapeutics (NKTR) operate in?

Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Nektar Therapeutics Stock (NASDAQ: NKTR) stock price, news, charts, stock research, profile.

Open	$1.19
Close	$1.16
Volume / Avg.	817.29K / 1.50M
Day Range	$1.13 - $1.20
52 Wk Range	0.41 - 1.93
Market Cap	$213.53M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	5.39%
Days to Cover	10.23

Recent News

Nektar's Q2 Earnings Lag Estimates, Revenues Top

Nektar Therapeutics (NASDAQ: NKTR) incurred a loss per share of 25 cents in the second quarter of 2024, which was wider than the Zacks Consensus Estimate of a loss of 21 cents.

Zacks

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin.

Avi Kapoor

Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol met the primary and secondary endpoints.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

2.0

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.19
Close	$1.16
Volume / Avg.	817.29K / 1.50M
Day Range	$1.13 - $1.20
52 Wk Range	0.41 - 1.93
Market Cap	$213.53M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	5.39%
Days to Cover	10.23

About Nektar Therapeutics

Sector

Health Care

Industry

Pharmaceuticals

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pip...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Nektar Therapeutics (NKTR) stock?

You can purchase shares of Nektar Therapeutics (NASDAQ:NKTR) through any online brokerage.

View our list of the best stock brokerages

Who are Nektar Therapeutics (NKTR) competitors?

Other companies in Nektar Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and Xeris Biopharma Holdings (NASDAQ:XERS).

What is the forecast, or price target, for Nektar Therapeutics (NKTR) stock?

Nektar Therapeutics has a consensus price target of $5.88.

What is the current price for Nektar Therapeutics (NKTR)?

The stock price for Nektar Therapeutics (NASDAQ: NKTR) is $1.16 last updated September 25, 2024 at 4:00 PM EDT.

Does Nektar Therapeutics (NKTR) pay a dividend?

There are no upcoming dividends for Nektar Therapeutics.

When is Nektar Therapeutics (NASDAQ:NKTR) reporting earnings?

Nektar Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.

Is Nektar Therapeutics (NKTR) going to split?

There is no upcoming split for Nektar Therapeutics.

What sector and industry does Nektar Therapeutics (NKTR) operate in?

Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge